Aventis
Aventis was a global pharmaceutical company formed in 1999 through the merger of Hoechst AG and Rhodia. It specialized in research and development of innovative medicines, focusing on areas such as cardiovascular health, oncology, and vaccines. The company aimed to improve patient care and health outcomes worldwide.
In 2004, Aventis was acquired by Sanofi-Synthélabo, leading to the creation of Sanofi-Aventis, which later became known simply as Sanofi. This merger expanded Sanofi's portfolio and strengthened its position in the global pharmaceutical market, continuing the legacy of Aventis in advancing healthcare solutions.